Similar articles

• Cancer-associated fibroblast regulation by microRNAs promotes invasion of oral squamous cell carcinoma.

  Matos LL, Menderico Junior GM, Theodoro TR, Pasini FS, Ishikawa MM, Ribeiro AAB, de Mello ES, Pinhal MADS, Moyses RA, Kulcsar MAV, Dedivitis RA, Cernea CR, Kowalski LP. Matos LL, et al. Oral Oncol. 2020 Nov;110:104909. doi: 10.1016/j.oraloncology.2020.104909. Epub 2020 Jul 20. Oral Oncol. 2020. PMID: 32702628
• Invasion-Related Factors as Potential Diagnostic and Therapeutic Targets in Oral Squamous Cell Carcinoma-A Review.

  Siriwardena SBSM, Tsunematsu T, Qi G, Ishimaru N, Kudo Y. Siriwardena SBSM, et al. Int J Mol Sci. 2018 May 14;19(5):1462. doi: 10.3390/ijms19051462. Int J Mol Sci. 2018. PMID: 29758011 Free PMC article. Review.
• Circulatory microRNAs inhibition and its signaling pathways in the treatment of oral squamous cell carcinoma (OSCC).

  Sekar D. Sekar D. Oral Oncol. 2022 Mar;126:105763. doi: 10.1016/j.oraloncology.2022.105763. Epub 2022 Feb 7. Oral Oncol. 2022. PMID: 35144207 No abstract available.
• [p53 gene therapy for oral cancer].

  Liu SX, Hu M. Liu SX, et al. Zhonghua Kou Qiang Yi Xue Za Zhi. 2012 Sep;47(9):569-72. doi: 10.3760/cma.j.issn.1002-0098.2012.09.016. Zhonghua Kou Qiang Yi Xue Za Zhi. 2012. PMID: 23141735 Review. Chinese. No abstract available.
• MICRORNA-31 AS A POTENTIAL THERAPEUTIC BIOMARKER FOR ORAL SQUAMOUS CELL CARCINOMA: CURRENT EVIDENCE AND FUTURE PROSPECTS.

  Krishnan M, Babu S, Jayaraman S, Daniel P, Solomon A, Chinnaiyan M. Krishnan M, et al. Exp Oncol. 2022 Nov;44(3):263-264. doi: 10.32471/exp-oncology.2312-8852.vol-44-no-3.18569. Exp Oncol. 2022. PMID: 36325699 No abstract available.